Absci Corporation (ABSI) vs Generate Biomedicines, Inc. (GENB)
A side-by-side comparison of Absci Corporation and Generate Biomedicines, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABSI
Absci Corporation
$11.77HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
GENB
Generate Biomedicines, Inc.
$13.99HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
Total return — ABSI vs GENB
growth of $100 · dividends reinvested · last 1yABSI +310.3% (+310.3%/yr)GENB +10.0% (+10.0%/yr)ABSI compounded faster over this window
ABSI GENB
ABSI vs GENB: by the numbers
- •ABSI is the larger company ($1.99B vs $1.79B market cap).
- •Both run net losses; GENB's is the smaller (-636.99% vs -7756.37% net margin).
Metrics side by side
Valuation
| Metric | ABSI | GENB |
|---|---|---|
| P/S ratio | 1277.28 | N/A |
| P/B ratio | 8.10 | 3.93 |
Profitability
| Metric | ABSI | GENB |
|---|---|---|
| Gross margin | -319.36% | 100.00% |
| Operating margin | -4454.21% | -737.04% |
| Net margin | -7756.37% | -636.99% |
| ROE | -49.19% | N/A |
| ROIC | -52.66% | -94.79% |
Growth (annualized)
| Metric | ABSI | GENB |
|---|---|---|
| Revenue CAGR (5Y) | -22.08% | N/A |
| Total return CAGR (5Y) | 0.89% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.